ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ODX Omega Diagnostics Group Plc

2.20
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Omega Diagnostics Group Plc LSE:ODX London Ordinary Share GB00B1VCP282 ORD 4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.20 2.00 2.40 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Omega Diagnostics Share Discussion Threads

Showing 3001 to 3025 of 37200 messages
Chat Pages: Latest  132  131  130  129  128  127  126  125  124  123  122  121  Older
DateSubjectAuthorDiscuss
03/4/2019
20:09
Hyperboreus

The old rules applied up until 2016 (close period )Nowadays more commonly known as closed period. INMO no company in their right mind would not have a closed period pending a trading update if directors have sat in board meetings and have been privileged to any price sensitive information.

Hopefully we may see some buying by them after the trading update with also buying from connected parties who may also be precluded from trading at the moment.

upomega
03/4/2019
19:28
As far as I am aware there is absolutely nothing to preclude any Director buying shares ahead of a trading update but so lovely to have an excellent well constructed post on this thread bomber13 👍
hyperboreus
03/4/2019
19:19
Nobody likes a falling share price ahead of a trading update for understandable reasons , but I would just like to make the following points -

1) The trades today were predominantly in very odd shapes , and the seller(s) took well below the then prevailing bid price , which may mean no more than some end of tax year finessing , or a forced seller , so not necessarily a knowledgeable pre-emptive strike ?

2) The new NED , Sneller's brother-in-law , only took up his role on 1st March after a lengthy selection process , and not only is his background investment banking , so for Omega much needed advice on stock market ways , but he is also destined to be on the audit and remuneration committee . As such , I suspect he did some thorough due diligence ( good news hopefully ), and may also buy shares in Omega post the close season , when he is allowed to ?

3) Colin King has pretty much delivered what he said was on the tin since taking the reins last year . His recent comments post the CD4 news , admittedly to the Scottish Herald , have been upbeat . I would also point out that he still has some decent sized options he could vest at 50p a share .

4) Food Intolerance is key to this trading update because it is the one segment of the three that currently makes real money , i.e. 33% operating margins . The interims in December showed sequential growth of 12% in half-yearly revenues with the hope of more to come in the second half-year .

My glass is still half-full despite today , and I will certainly raise it to Colin King if he delivers those revenue aspirations he has previously talked about .

bomber13
03/4/2019
17:20
The way I see things is that the results will be lacklustre with further exceptional charges.i.e the new facilities.how I read it is that things will start to take off after September.regulatory clearance food intolerance in China.cd4 200 clearance if fast tracked as the company indicated.inmo its if the company can survive until then without a fundraise.even then it should not be for much
upomega
03/4/2019
17:15
I know but as you are aware they are no longer board members, a delayed trade of 110,526 @ 11.75p has just gone through, can't wait to see what tomorrow brings! 😱
hyperboreus
03/4/2019
17:06
David Evans held over 3% until he resigned, hope he is still holding all his. Andrew Shepherd held 2.5%....someone has been offloading...
barrywhit
03/4/2019
16:56
I totally agree with that but when you consider that the current Non-Exec Chairman Bill Rhodes has zero shares, Jag Grewal has only 153,246 and hasn't bought any since July '17, Colin King has 468,253 and Kieron Harbinson has 606,617.

By my calculation their TOTAL holding is less than 1% of shares in circulation which is both paltry and extraordinary, there surely cannot be many other AIM listed companies with a current Board of Directors with a combined shareholding less than 1%?

hyperboreus
03/4/2019
16:46
Hyperboreus.do you know for definite that the regulatory issue re food intolerance hasn't been sorted.ALso iwould imagine the directors are in a closed period before a trading update
upomega
03/4/2019
16:41
I thought the new director may have put his hand in his pocket and bought a few...
barrywhit
03/4/2019
16:28
... in addition what really doesn't help sentiment is that the Directors are not sticking their hands in their pockets and messrs Sneller & Mills must think they have shelled out enough already!
hyperboreus
03/4/2019
16:25
Well I do not envisage that the expected trading update will bring that much cheer to long suffering shareholders as the ongoing regulatory issue regarding Food Intolerance doesn't appear to have been resolved and 'other' revenue avenues are not likely to amount to anything of significance.

Key thing right now for me is how much cash they have burned since November 18, the Company has a committed overdraft facility of £2m provided by Bank of Scotland up and until June of this year so any reassuring news on that front would be very welcome.

I think the share price is likely to get hammered even more if there is no positive news or even guidance regarding CD4 regulatory approval and/or sales.

hyperboreus
03/4/2019
16:22
I’m afraid if we have no buyers then there is only one direction it will go. Hopefully we will get a few buys at start of the new financial year..
barrywhit
03/4/2019
15:20
I hope this isn't a prelude to the trading update. We really could do with a sizeable cd4 350 order from Nigeria.As previously indicated
upomega
03/4/2019
10:10
What does WHO recommend?
WHO guidelines recommend that a defined package of care interventions, which includes screening, treatment and prophylaxis for major opportunistic infections, rapid initiation of ART and intensified treatment adherence support, should be provided to patients presenting with advanced HIV disease to reduce associated morbidity and mortality. This package should be offered to all people presenting with advanced HIV disease including those who are re-engaging with care after a period of ART interruption.
Baseline CD4 cell count testing remains clinically important
in order to identify those who have advanced HIV disease
and who should be offered this package of care interventions.
Components of the package of care interventions
Several large randomized trials have shown that providing
a package of care interventions can reduce morbidity and mortality associated with advanced HIV disease. The individual components contained within the package of care interventions are already recommended by WHO, and are brought together in a standardized, simplified and evidence-informed package of HIV priority interventions.
New recommendation
A package of interventions including screening, treatment and/or prophylaxis for major opportunistic infections,
rapid ART initiation and intensified adherence support interventions should be offered to everyone presenting with advanced HIV disease (strong recommendation, moderate- quality evidence).

barrywhit
03/4/2019
09:57
I had a dig at the Omega board at the back end of last year. I tried to involve humour but it backfired.
gwr7
03/4/2019
09:41
Norti Raskal
raskal
03/4/2019
09:40
Exclusive Distributor
A legal representative for Omega Diagnostics laboratories, Scotland, United kingdom.
January 2018 – Present 1 year 4 months

Nigerian Territory

Distribution and marketing of Visitect CD4 point of care rapid test kit which determines the baseline for CD4 in people living with Hiv.

raskal
03/4/2019
09:35
I am Norti Raskal and I am King of the Castle and ask What other company is Andrew Sheppherd involved with?
raskal
03/4/2019
09:33
Majekodunmi Aborode
Exclusive Distributor and legal representative for Omega Diagnostics laboratories, Scotland, UK, in Nig. Territory.

raskal
03/4/2019
09:30
Alf hasn't been averse to having a dig at the board and I approve.

"alftupper 17 May '17 - 17:07 - 9368 of 19012
Some perspective on the most successful fundraise ever. Given that two institutions came on board for the first time and they were classified as major institutions then their minimum ticket size would be £1m that then leaves £3m divided between 16 institutions = £187.5k each. The mark of success would not include a 42% discount to the last round of 13months ago. There is a disconnect here regarding timing - if there are significant value enhancing events coming soon why do the fundraise now - unless of course you are desperate."

gwr7
03/4/2019
08:53
What was the other alias out of interest, I only remember the one.
arthur_lame_stocks
03/4/2019
08:44
The use of two aliases caused consternation at first, but all seemed happy they were both David Evans.
gwr7
03/4/2019
08:18
FWIW I phoned NXC on the number he provided and had a decent chat with him so it wasn't a fake account.
arthur_lame_stocks
03/4/2019
08:07
Norti raskal, oh behave. I hope alf 'tough of the track' tupper hasn't created another one ;)
gwr7
01/4/2019
15:13
Or is it GLOBAL DX? They are connected in some way. The answer is in Linkedin. I am Norti Raskal and I will always be king of the castle.
raskal
Chat Pages: Latest  132  131  130  129  128  127  126  125  124  123  122  121  Older

Your Recent History

Delayed Upgrade Clock